Bevacizumab effect minimal after trabeculectomy

ORLANDO, Fla. — The success of bevacizumab in changing the outcome of IOP, bleb vascularization and fibrosis after trabeculectomy was not significant, according to a poster presentation here at the Association for Research in Vision and Ophthalmology meeting. “We didn’t get the final result that we were hoping for,” co-author Catherine M. Birt, MD, FRCSC, told Ocular Surgery News. “There were some encouraging indicators that the study group was doing better, but the differences did not reach a statistical significance; therefore, we are not on the basis of these data (Read more...)